You are in: eMedicine Specialties > Medicine, Ob/Gyn, Psychiatry, and Surgery > Urology
|
Epididymitis Last Updated: February 2, 2006 |
|
| Synonyms and related keywords: epididymitis, epididymo-orchitis,
orchitis, epididymis,
testicular torsion,
bladder outlet obstruction, BOO,
urethral stricture,
ectopic ureter, ectopic vas deferens, prostatic utricle, urethral duplication, posterior urethral valves,
urethrorectal fistula, detrusor sphincter dyssynergia,
vesicoureteral reflux,
benign prostatic hyperplasia, BPH, sexually transmitted diseases, STDs,
inflammation of the epididymis,
epididymal pain,
acute epididymitis,
chronic epididymitis,
urethritis,
prostatitis,
tuberculous epididymitis,
genitourinary tuberculosis,
genitourinary TB,
mumps orchitis, urogenital malformations, scrotal pain, scrotal swelling,
urethral discharge,
parotiditis, funiculitis,
Prehn sign,
reactive hydrocele, beading of the vas deferens, scrotal cellulitis, urinary coliforms,
Chlamydia,
Neisseria gonorrhoeae,
Ureaplasma urealyticum,
Treponema pallidum,
Trichomonas,
Gardnerella vaginalis, sterile reflux,
urethro-vasal reflux,
amiodarone epididymitis,
trauma to the scrotum,
brucellosis,
coccidioidomycosis,
blastomycosis,
cytomegalovirus,
candidiasis,
coxsackievirus type A,
varicella,
echoviral infections
|
|   |
AUTHOR INFORMATION
| Section 1 of 11  |
|
| Author: Badrinath R Konety, MD, Associate Professor, Department of Urology, University of California at San Francisco Coauthor(s): Michael Franks, MD, Staff Physician, Department of Urology, University of Pittsburgh Medical Center |
| Badrinath R Konety, MD, is a member of the following medical societies:
American College of Surgeons,
American Urological Association, and
International College of Surgeons |
| Editor(s): Erik T Goluboff, MD, Program Director, Assistant Professor, Department of Urology, Columbia-Presbyterian Medical Center, Columbia University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine;
Laurence Klotz, MD, Professor, Department of Surgery, University of Toronto School of Medicine, Canada;
J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center;
and Stephen W Leslie, MD, FACS, Founder and Medical Director, Lorain Kidney Stone Research Center; Clinical Assistant Professor, Department of Urology, Medical College of Ohio; Chief Editor - eMedicine Urology |
Disclosure
|   |
INTRODUCTION
| Section 2 of 11  |
|
Background: Acute epididymitis is an inflammation of the epididymis. It is a significant cause of morbidity and is frequently observed by urologists, emergency medicine practitioners, and primary care physicians. When infection is severe and extends to the adjacent testicle, acute epididymo-orchitis is typically present. Chronic epididymitis refers to epididymal pain and inflammation (usually without scrotal swelling) that lasts for more than 6 months. Much less common, orchitis is an acute inflammatory reaction of only the testes, exclusive of epididymitis. Hippocrates first described mumps orchitis during the fifth century BC. Pathophysiology: Acute epididymitis is thought to be caused by a retrograde passage of infected urine from the prostatic urethra to the epididymis via the ejaculatory ducts and vas deferens. Obstruction of the prostate or urethra and congenital anomalies creates a predisposition for sterile or urethro-vasal reflux, which normally does not occur. (The oblique angle of the ejaculatory ducts through the dense prostatic tissue usually prevents reflux.)
Instrumentation and indwelling catheters are common risk factors for acute epididymitis. Urethritis or prostatitis can also coexist. Tuberculous epididymitis may be the presenting feature of genitourinary tuberculosis (TB), which occurs through hematogenous spread. Orchitis differs from epididymitis in that a viral pathogen (mumps) is an important factor.
Reflux may be induced by Valsalva or strenuous exertion. Epididymitis is common in men performing strenuous exertion when there is no opportunity to void, resulting in a full bladder. Frequency:
- In the US: An estimated 1 in 1000 men is affected yearly, and there are more than 600,000 medical visits per year for acute epididymitis. The mumps, measles, and rubella (MMR) vaccine has markedly reduced the incidence of mumps orchitis.
- Internationally: In the United Kingdom, there are 13,000 medical visits per year for acute epididymitis.
Race: Epididymitis and orchitis have no predilection for any racial or ethnic group.
Age:
- Acute epididymitis most commonly occurs in patients aged 15-30 years and patients older than 60 years. Childhood (prepubertal) epididymitis is rare, and testicular torsion is much more common in this age group.
- Structural urologic abnormalities are common in children and in men older than 40 years with acute epididymitis. Adults usually have bladder outlet obstruction (BOO) or urethral stricture; children may have an ectopic ureter, ectopic vas deferens, prostatic utricle, urethral duplication, posterior urethral valves, urethrorectal fistula, detrusor sphincter dyssynergia, or vesicoureteral reflux. According to the study from Merlini et al, 7 of 11 infants with documented bacteruria had reflux or urogenital malformations, while only 3 of 14 children older than 1 year had associated anatomical abnormalities.
- Mumps orchitis occurs in 20-40% of postpubertal boys with the mumps; it is rare in prepubertal boys.
|   |
CLINICAL
| Section 3 of 11  |
|
History: - Acute epididymitis and orchitis
- Gradual onset of scrotal pain and swelling
- Dysuria, frequency, urgency
- Fever and chills occur in only 25% of patients with acute epididymitis.
- Urethral discharge may precede acute epididymitis by more than 30 days or may not occur at all.
- Fever, malaise, and myalgia
- Parotiditis typically precedes the onset of orchitis by 3-5 days.
- Subclinical infections occur in 30-40% of patients.
Physical: - Tenderness and induration first occur in the epididymal tail, then the body, and then the spermatic cord (funiculitis) or the ipsilateral testis (epididymo-orchitis).
- Prehn sign: Elevation of the affected hemiscrotum relieves the pain of epididymitis and exacerbates the pain of torsion. Manual detorsion of the affected testis may dramatically reduce pain in children with torsion.
- Physical examination findings may be unable to distinguish acute epididymitis from testicular torsion because early torsion also involves only the epididymis. A normal cremasteric reflex makes testicular torsion less likely.
- Acute epididymitis is bilateral in 5-10% of the patients.
- Erythema and mild scrotal cellulitis may be present.
- A reactive hydrocele is frequent with advanced epididymo-orchitis, which makes a scrotal examination difficult.
- TB can cause focal epididymitis, a draining sinus, or classical beading of the vas deferens with extensive involvement. Orchitis rarely occurs without epididymitis in TB.
- Testicular enlargement, induration, and a reactive hydrocele commonly occur.
- The epididymis is not tender.
Causes: - Etiology of acute epididymo-orchitis
- Nonspecific bacterial infections: Urinary coliforms (eg, Escherichia coli, pseudomonads) are more common in children and in men older than 40 years. Systemic infections from Haemophilus influenzae or Neisseria meningitides are rare. TB can occur in endemic areas.
- Sexually transmitted diseases (STDs): Chlamydia is most commonly identified (50%). Neisseria gonorrhoeae, Ureaplasma urealyticum, Treponema pallidum, Trichomonas, and Gardnerella vaginalis are also observed.
- Sterile reflux or urethro-vasal reflux may occur.
- Obstruction: Adults older than 40 years usually have a BOO (eg, benign prostatic hyperplasia [BPH]) or urethral stricture; children may have various congenital abnormalities or functional voiding problems.
- Amiodarone epididymitis is secondary to drug concentration, usually in the head of the epididymis, and can occur in as many as 3-11% of patients on the drug. This is a dose-dependent phenomenon, and typically occurs at dosages greater than 200 mg daily. Histological analysis reveals focal fibrosis and lymphocytic infiltration of epididymal tissues.
- Trauma to the scrotum can be a precipitating event.
- Other rare infections (eg, brucellosis, coccidioidomycosis, blastomycosis, cytomegalovirus (CMV), candidiasis, CMV in HIV) usually occur in immunocompromised hosts.
- Etiology of acute orchitis
- Viral: Mumps orchitis is most common. Coxsackievirus type A, varicella, and echoviral infections are rare.
- Bacterial and pyogenic infections: E coli, Klebsiella, Pseudomonas, Staphylococcus, and Streptococcus species are unusual.
- Granulomatous: T pallidum, Mycobacterium tuberculosis, Mycobacterium leprae, Actinomyces, and fungal diseases are rare.
|   |
DIFFERENTIALS
| Section 4 of 11  |
|
Hydrocele Scrotal Trauma Testicular Seminoma Testicular Torsion Testicular Trauma
Other Problems to be Considered:
Scrotal hernia
Idiopathic scrotal edema
Reactive hydrocele
Pyocele
Henoch-Schönlein purpura
Behçet disease
Polyarteritis nodosa
Vasculitis |
|
|   |
WORKUP
| Section 5 of 11  |
|
Lab Studies:
- Acute epididymitis and nonviral orchitis
- WBC count can be elevated with a left shift (10,000-30,000 cells/mm3).
- Urinalysis findings are positive for pyuria in only 25% of patients.
- Performing a midstream urine culture and Gram stain are useful to guide therapy.
- Obtain a urethral swab culture (before void, after prostate massage) for gonorrheal and chlamydial infections if the patient is in the right age group or if the patient is older than 40 years and not monogamous.
- Perform blood cultures if the patient is systemically ill.
- Use immunofluorescent antibody testing to confirm the diagnosis if a clinical doubt exists.
- Urinalysis and culture findings are negative.
- Amiodarone plasma levels or antibodies are not helpful in the diagnosis of amiodarone-induced epididymitis.
Imaging Studies:
- Use imaging studies to help distinguish acute epididymitis from the more ominous testicular torsion. Do not allow studies to delay intervention or exploration if testicular torsion is suspected because testicular viability drops significantly with delay.
- This test is the most widely available; however, it is examiner dependent. The pain and patient size (infants) can limit the examination.
- Increased blood flow occurs with epididymitis; no flow occurs with torsion. Testicular tumors can also appear hyperemic.
- Use ultrasound to help detect a scrotal abscess as well as complications of epididymitis and bacterial or pyogenic orchitis.
- Sensitivity for torsion is 82-100%, and specificity is 100%.
- Use technetium Tc 99m scanning.
- Acute epididymitis shows an increased tracer uptake, while a defect in uptake in the scrotum occurs with torsion.
- Availability, cost, and difficulty with interpretation limit usefulness.
- Sensitivity for torsion is 90-100%, and specificity is 89-97%.
- False-positive study results occur with a hydrocele and abscess. False-negative study results can occur with spontaneous detorsion and intermittent torsion.
- Radiologic studies are recommended in children and in adults older than 40 years who have bacteruria and acute epididymitis in order to evaluate for structural abnormalities, which are present in more than 50% of these patients. In infants with bacteruria and epididymitis, in whom anatomical abnormalities are more common than in older children, a vesicoureterogram (VCUG) and abdominal ultrasound are recommended. A retrograde urethrogram is also indicated for identification of urethral stricture disease as symptoms dictate.
- Radiologic studies for mumps orchitis are not indicated, although a reactive hydrocele is common.
Procedures:
- Cystourethroscopy: Along with radiological evaluation, a cystourethroscopy is essential in the diagnosis of structural abnormalities present in children and older adults, as radiographic and clinical suspicion dictates.
|   |
TREATMENT
| Section 6 of 11  |
|
Medical Care: - In addition to antibiotics, the mainstays of supportive therapy for acute epididymitis and orchitis are as follows:
- Scrotal support and elevation
Surgical Care: - Perform a scrotal exploration if the torsion or tumor cannot be ruled out and for the complications of acute epididymitis and orchitis (eg, abscess, pyocele, testicular infarction).
- Diagnosis of intrascrotal disorders is often confirmed at orchiectomy.
- Epididymectomy: This procedure has limited utility in treating the pain of chronic epididymitis. Twenty-five percent of affected men continue to have scrotal discomfort after epididymectomy. Therefore, reserve surgery for refractory cases only.
- Epididymotomy: Conduct this procedure infrequently in patients with acute suppurative epididymitis.
- Viral mumps has no surgical indications.
- Refractory pain with chronic epididymitis and orchalgia has rarely been managed by skeletonization of the spermatic cord, as performed with a subinguinal varicocelectomy.
Consultations: - Obtain consultation with a urologist if testicular torsion is suspected, or with complications of failed medical treatment.
|   |
MEDICATION
| Section 7 of 11  |
|
Nonspecific bacterial epididymitis and orchitis require empiric treatment with trimethoprim-sulfamethoxazole or a fluoroquinolone antibiotic for 2 weeks. Systemic illness warrants hospitalization and coverage with IV ampicillin and gentamicin. Additionally, use blood and urine cultures to guide therapy.
Consider sexually transmitted epididymitis in men aged 15-35 years who are sexually active; however, STDs must also be considered in children and adults based on history and context. Empiric therapy consists of ceftriaxone and doxycycline for 10 days. A single dose of azithromycin is an alternative to doxycycline, which may improve compliance. Specific treatment of gonococcal infection includes ceftriaxone as first choice and ofloxacin or ciprofloxacin as the second choice. Nongonococcal infections are treated with doxycycline or, alternatively, azithromycin or tetracycline. Both sexual partners must be treated. Antitubercular triple therapy consists of rifampin, isoniazid, and pyrazinamide for 4 months.
Amiodarone epididymitis usually responds to dosage reduction or discontinuation. Mumps orchitis and traumatic and idiopathic epididymitis require no specific therapy other than supportive measures. The efficacy of alpha interferon and gonadotropin-releasing hormone (GRH) therapy for the treatment of mumps orchitis is currently unproven.
Drug Category: Antibiotics -- Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting. Drug Name
| Ceftriaxone (Rocephin) -- Third-generation cephalosporin with broad-spectrum gram-negative activity; lower efficacy against gram-positive organisms; higher efficacy against resistant organisms. Arrests bacterial growth by binding to one or more penicillin-binding proteins. |
|---|
| Adult Dose | 250 mg IM qd (one-time dose), or divided bid; not to exceed 4 g/d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Probenecid may increase levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Adjust dose in renal impairment; caution in breastfeeding women and penicillin allergy |
|---|
Drug Name
| Doxycycline (Doryx, Vibramycin) -- Treatment for Chlamydia trachomatis. Inhibits protein synthesis and thus bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria. |
|---|
| Adult Dose | 100 mg PO bid for 7-14 days |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; severe hepatic dysfunction |
|---|
| Interactions | Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy |
|---|
| Pregnancy |
D - Unsafe in pregnancy
|
|---|
| Precautions | Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines |
|---|
Drug Name
| Azithromycin (Zithromax) -- Acts by binding to 50S ribosomal subunit of susceptible microorganisms and blocks dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Nucleic acid synthesis is not affected.
Concentrates in phagocytes and fibroblasts as demonstrated by in vitro incubation techniques. In vivo studies suggest that concentration in phagocytes may contribute to drug distribution to inflamed tissues. Used for treatment of gonococci, Chlamydia, or both.| Adult Dose | C trachomatis: 1 g PO as single dose Chlamydia and gonococci: 2 g PO as single dose |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; hepatic impairment; do not administer with pimozide |
|---|
| Interactions | May increase toxicity of theophylline, warfarin, and digoxin; effects are reduced with coadministration of aluminum and/or magnesium antacids; nephrotoxicity and neurotoxicity may occur when coadministered with cyclosporine |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Site reactions can occur with IV route; bacterial or fungal overgrowth may result with prolonged antibiotic use; may increase hepatic enzymes and cholestatic jaundice; caution in patients with impaired hepatic function, prolonged QT intervals, or pneumonia; caution in hospitalized, geriatric, or debilitated patients |
|---|
|
|---|
Drug Name
| Ofloxacin (Floxin) -- Penetrates prostate well and is effective against N gonorrhea and C trachomatis. A pyridine carboxylic acid derivative with broad-spectrum bactericidal effect. |
|---|
| Adult Dose | 400 mg PO bid for 14 d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
|---|
| Pregnancy |
D - Unsafe in pregnancy
|
|---|
| Precautions | In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
|---|
Drug Name
| Ciprofloxacin (Cipro) -- For bacterial infections. Not effective for nongonococcal infections, such as Chlamydia. |
|---|
| Adult Dose | 500 mg PO bid for 14 d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; reduces therapeutic effects of phenytoin; probenecid may increase serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
|---|
| Pregnancy |
D - Unsafe in pregnancy
|
|---|
| Precautions | In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
|---|
Drug Name
| Trimethoprim-sulfamethoxazole (Bactrim, Bactrim DS, Septra, Septra DS) -- For empiric treatment of nonspecific bacterial infection. |
|---|
| Adult Dose | 1 tab PO bid for 14 d |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT) |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy |
|---|
Drug Category: Antituberculous drugs -- For treatment of tuberculous epididymo-orchitis.Drug Name
| Rifampin (Rifadin, Rimactane) -- Part of the triple-drug regimen. For use in combination with at least one other antituberculous drug; inhibits DNA-dependent bacterial but not mammalian RNA polymerase. Cross-resistance may occur. Treat for 6-9 mo or until 6 mo have elapsed from conversion to sputum culture negativity. |
|---|
| Adult Dose | 450 mg PO qd for 2 mo 900 mg PO qd for additional 2 mo |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Induces microsomal enzymes, which may decrease effects of acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, beta-blockers, chloramphenicol, oral contraceptives, corticosteroids, mexiletine, cyclosporine, digitoxin, disopyramide, estrogens, hydantoins, methadone, clofibrate, quinidine, dapsone, tazobactam, sulfonylureas, theophyllines, tocainide, and digoxin; blood pressure may increase with coadministration of enalapril; coadministration with isoniazid may result in higher rate of hepatotoxicity than with either agent alone (discontinue one or both agents if alterations in LFTs occur) |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Obtain CBC counts and baseline clinical chemistries prior to and throughout therapy; in liver disease, weigh benefits against risk of further liver damage; interruption of therapy and high-dose intermittent therapy are associated with thrombocytopenia that is reversible if therapy is discontinued as soon as purpura occurs; if treatment is continued or resumed after appearance of purpura, cerebral hemorrhage or death may occur |
|---|
Drug Name
| Isoniazid (Laniazid, Nydrazid) -- An isonicotinic acid hydrazide (INH), which is part of the triple-drug regimen. |
|---|
| Adult Dose | 300 mg PO qd for 2 mo 600 mg PO qd for additional 2 mo |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; previous isoniazid-associated hepatic injury or other severe adverse reactions |
|---|
| Interactions | Higher incidence of isoniazid-related hepatitis can occur with daily alcohol ingestion; aluminum salts may decrease isoniazid serum levels (administer 1-2 h before taking aluminum salts); may increase anticoagulants effects with coadministration; may inhibit metabolic clearance of benzodiazepines; carbamazepine toxicity or isoniazid hepatotoxicity may result from concurrent use (monitor carbamazepine concentrations and liver function); coadministration with cycloserine may increase adverse CNS effects (eg, dizziness); acute behavioral and coordination changes may occur with coadministration of disulfiram; coadministration with rifampin after halothane anesthesia may result in hepatotoxicity and hepatic encephalopathy; may inhibit hepatic microsomal enzymes and increase toxicity of hydantoin |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Monitor patients with active chronic liver disease or severe renal dysfunction; periodic ophthalmologic examinations during isoniazid therapy are recommended even when visual symptoms do not occur |
|---|
Drug Name
| Pyrazinamide -- Pyrazine analog of nicotinamide that may be bacteriostatic or bactericidal against M tuberculosis, depending on concentration of drug attained at site of infection; mechanism of action is unknown. Part of the triple-drug regimen. |
|---|
| Adult Dose | 25 mg/kg/d PO for first 2 mo only |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; severe hepatic damage, acute gout |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Use only in combination with other effective antituberculous agents; inhibits renal excretion of urates; may result in hyperuricemia (usually asymptomatic); perform baseline serum uric acid determinations; discontinue drug if signs of hyperuricemia with acute gouty arthritis; perform baseline LFTs (closely monitor in liver disease); discontinue pyrazinamide if signs of hepatocellular damage appear; caution in history of diabetes mellitus |
|---|
|   |
FOLLOW-UP
| Section 8 of 11  |
|
Complications:
- Acute epididymitis and bacterial orchitis
- Scrotal abscess and pyocele
- Testicular infarction: Cord swelling can limit testicular artery blood flow.
- Recurrence, chronic epididymitis, orchalgia: True local pain can be distinguished from referred pain by spermatic cord injection with 1% lidocaine. Refractory pain that is not improved by analgesics has also been managed by skeletonization of the spermatic cord, as with a varicocelectomy.
- Sterility is uncommon after acute epididymitis, although the documented true incidence is unknown. Disturbances in the sperm quality secondary to leukocytospermia and inflammation are usually transient. More important is the far less common azoospermia, which is caused by the epididymal duct obstruction observed in untreated and improperly treated men with epididymitis. The incidence of this condition is unknown.
- Hypogonadotropic hypogonadism can occur as a result of testicular atrophy, which is observed in 30-50% of patients.
- Sterility occurs in 7-13% of affected patients. Orchitis affects the testicular interstitium more than the Leydig and Sertoli cells, but sperm counts, mobility, and morphology can be affected.
- Mumps orchitis is not associated with the development of testicular tumors.
Patient Education:
|   |
MISCELLANEOUS
| Section 9 of 11  |
|
Medical/Legal Pitfalls:
- Misdiagnosis of testicular torsion is a potential pitfall.
- Failure to recognize and treat both partners for STDs is a potential pitfall. Symptoms and positive culture findings are often absent.
|   |
PICTURES
| Section 10 of 11  |
|
| Caption: Picture 1. Color Doppler ultrasound image of the left epididymis in a patient with acute epididymitis. The image demonstrates increased blood flow in the epididymis resulting from the active inflammation.
|  | View Full Size Image |
|
Picture Type: Photo |
| Caption: Picture 2. Scrotal ultrasonography demonstrating the presence of a hydrocele and an enlarged epididymis in a patient with epididymitis. The echogenic white area is the normal testicle surrounded by the hydrocele. |  | View Full Size Image |
|
Picture Type: Photo |
| Caption: Picture 3. Scrotal ultrasound image showing the testes adjacent to the inflamed epididymis with a reactive hydrocele. |  | View Full Size Image |
|
Picture Type: Photo |
|   |
BIBLIOGRAPHY
| Section 11 of 11 |
|
-
Alves LS, Assis BP, Rezende MM: Schistosomal epididymitis. Int Braz J Urol 2004 Sep-Oct; 30(5): 413-5[Medline].
-
Berger RE: Sexually Transmitted Diseases: The Classic Diseases. In: Campbell's Urology. Vol 1. 7th ed. 1997: 670-683.
-
Cappele O, Liard A, Barret E, et al: Epididymitis in children: is further investigation necessary after the first episode? Eur Urol 2000 Nov; 38(5): 627-30[Medline].
-
Donzella JG, Merrick GS, Lindert DJ, et al: Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Urology 2004 Feb; 63(2): 306-8[Medline].
-
Drury NE, Dyer JP, Breitenfeldt N, et al: Management of acute epididymitis: are European guidelines being followed? Eur Urol 2004 Oct; 46(4): 522-4; discussion 524-5[Medline].
-
Furuya R, Takahashi S, Furuya S, et al: Is seminal vesiculitis a discrete disease entity? Clinical and microbiological study of seminal vesiculitis in patients with acute epididymitis. J Urol 2004 Apr; 171(4): 1550-3[Medline].
-
Gabal-Shehab LL, Monga M: Recurrent bilateral amiodarone induced epididymitis. J Urol 1999 Mar; 161(3): 921[Medline].
-
Höppner W, Strohmeyer T, Hartmann M, et al: Surgical treatment of acute epididymitis and its underlying diseases. Eur Urol 1992; 22(3): 218-21[Medline].
-
Haecker FM, Hauri-Hohl A, von Schweinitz D: Acute epididymitis in children: a 4-year retrospective study. Eur J Pediatr Surg 2005 Jun; 15(3): 180-6[Medline].
-
Herbener TE: Ultrasound in the assessment of the acute scrotum. J Clin Ultrasound 1996 Oct; 24(8): 405-21[Medline].
-
Ireton RC, Berger RE: Prostatitis and epididymitis. Urol Clin North Am 1984 Feb; 11(1): 83-94[Medline].
-
Kaver I, Matzkin H, Braf ZF: Epididymo-orchitis: a retrospective study of 121 patients. J Fam Pract 1990 May; 30(5): 548-52[Medline].
-
Krieger JN: Epididymitis, orchitis, and related conditions. Sex Transm Dis 1984 Jul-Sep; 11(3): 173-81[Medline].
-
Liu HY, Fu YT, Wu CJ, Sun GH: Tuberculous epididymitis: a case report and literature review. Asian J Androl 2005 Sep; 7(3): 329-32[Medline].
-
Luzzi GA, O'Brien TS: Acute epididymitis. BJU Int 2001 May; 87(8): 747-55[Medline].
-
Manson AL: Mumps orchitis. Urology 1990 Oct; 36(4): 355-8[Medline].
-
Melekos MD, Asbach HW: Epididymitis: aspects concerning etiology and treatment. J Urol 1987 Jul; 138(1): 83-6[Medline].
-
Merlini E, Rotundi F, Seymandi PL, Canning DA: Acute epididymitis and urinary tract anomalies in children. Scand J Urol Nephrol 1998 Jul; 32(4): 273-5[Medline].
-
Mittemeyer BT, Lennox KW, Borski AA: Epididymitis: a review of 610 cases. J Urol 1966 Mar; 95(3): 390-2[Medline].
-
Nickel JC, Teichman JM, Gregoire M, et al: Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study. Urology 2005 Nov; 66(5): 935-40[Medline].
-
Padmore DE, Norman RW, Millard OH: Analyses of indications for and outcomes of epididymectomy. J Urol 1996 Jul; 156(1): 95-6[Medline].
-
Siegel A, Snyder H, Duckett JW: Epididymitis in infants and boys: underlying urogenital anomalies and efficacy of imaging modalities. J Urol 1987 Oct; 138(4 Pt 2): 1100-3[Medline].
-
Thind P, Gerstenberg TC, Bilde T: Is micturition disorder a pathogenic factor in acute epididymitis? An evaluation of simultaneous bladder pressure and urine flow in men with previous acute epididymitis. J Urol 1990 Feb; 143(2): 323-5[Medline].
-
Viswaroop BS, Kekre N, Gopalakrishnan G: Isolated tuberculous epididymitis: A review of forty cases. J Postgrad Med 2005 Apr-Jun; 51(2): 109-11[Medline].
-
Weidner W, Krause W, Ludwig M: Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update 1999 Sep-Oct; 5(5): 421-32[Medline].
Epididymitis excerpt |